Showing results (151-160 of 379) with videos related to
Sort By:
Pageof 38
The Oncologist|May 9, 2026
Selective internal radiotherapy and chemosaturation show equivalent survival in metastatic uveal melanoma: a retrospective multicenter studyElias A T Koch, Louisa A Schielein, Markus Reitmajer, et al.European Journal of Cancer (Oxford, England : 1990)|June 16, 2018
Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockadeLaura Milsch, Anja Gesierich, Sophia Kreft, et al.Frontiers in Oncology|December 2, 2020
Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade: A Case ReportJohanna Matull, Elisabeth Livingstone, Axel Wetter, et al.British Journal of Pharmacology|March 11, 2026
Cardiac surveillance in immune checkpoint inhibitor therapy: Insights from the Essen Cardio-oncology RegistryElias Haj-Yehia, Lisa Zimmer, Lena Lampe, et al.Journal for Immunotherapy of Cancer|October 23, 2020
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patientsUlrike Leiter, Carmen Loquai, Lydia Reinhardt, et al.The Journal of Investigative Dermatology|December 11, 2012
Chemovirotherapy of malignant melanoma with a targeted and armed oncolytic measles virusJohanna K Kaufmann, Sascha Bossow, Christian Grossardt, et al.Deutsches Arzteblatt International|April 3, 2024
An Online Decision Aid for Patients With Metastatic Melanoma—Results of the Randomized Controlled Trial “PEF-Immun”Pia Grabbe, Milena S Borchers, Kathrin M Gschwendtner, et al.Diagnostic Pathology|May 23, 2013
Lack of SF3B1 R625 mutations in cutaneous melanomaBastian Schilling, Nicola Bielefeld, Antje Sucker, et al.Microorganisms|March 6, 2021
Impact of the Histidine-Containing Phosphocarrier Protein HPr on Carbon Metabolism and Virulence in Staphylococcus aureusLinda Pätzold, Anne-Christine Brausch, Evelyn-Laura Bielefeld, et al.Journal for Immunotherapy of Cancer|September 20, 2023
Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse eventsKarolina Gente, Leonore Diekmann, Lea Daniello, et al.Pageof 38